Trial Profile
Cardiovascular function with switching from Kivexa to Truvada (or from Abacavir to Tenofovir) in people with Human Immunodeficiency Virus (HIV).
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 16 Jul 2019
Price :
$35
*
At a glance
- Drugs Emtricitabine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Acronyms SKiT
- 08 Aug 2013 Status changed from recruiting to completed as reported by Australian New Zealand Clinical Trials Registry.
- 12 Jan 2009 New trial record.